Five Companies Are Building Space Stations. One Customer Exists.

$415 million.

That's what NASA has disbursed so far through its Commercial Low Earth Orbit Destinations program to help private companies design space stations. Phase 2 — worth $1 billion to $1.5 billion in contracts running through 2031 — is selecting winners this year. Five companies are competing for what amounts to NASA's blessing and NASA's checkbook.

Vast, Axiom Space, Voyager/Airbus (Starlab), Blue Origin's Orbital Reef consortium, and Northrop Grumman are all building or designing orbital habitats. Combined, they've raised or been allocated well over $2 billion. The pitch is always the same: the ISS retires around 2030, the commercial sector takes over, costs plummet, innovation soars.

Nobody wants to say the quiet part: every single business plan depends on a single customer paying above-market rates for patriotic reasons.

The Scorecard

Company	Station	Launch Target	Funding	Status
Vast	Haven-1	May 2026	$500M+ (private)	Flight hardware built, Falcon 9 booked
Axiom Space	Axiom Station	Module 1: 2026	$350M+ raised, NASA CLD Phase 1	Attaching first module to ISS, then detaches ~2028
Voyager / Airbus	Starlab	2028	NASA CLD + Airbus partnership	"Full-scale development," needs Starship for single-launch
Blue Origin / Sierra Space	Orbital Reef	~2028–2030	Bezos-backed + NASA CLD Phase 1	Ground mockup testing, Haven Demo deployed Nov 2025
Northrop Grumman	Unnamed station	Late 2020s	NASA CLD Phase 1	Conceptual design phase

Vast is closest to flying. Haven-1 — roughly the size of a shipping container, hosting crews of four for up to 10 days — will be the largest payload a Falcon 9 has ever carried at 31,000 pounds. Drew Feustel, Vast's lead astronaut and former NASA crew member, calls it "an amazing inflection point for human spaceflight." Maybe. It's also a $500 million proof-of-concept that can't generate meaningful revenue at that scale.

The NASA Dependency

The ISS costs NASA approximately $3 billion per year — about a third of the agency's human spaceflight budget. That number has remained roughly steady since 2016, though systems maintenance costs climbed 35% between FY2016 and FY2020 as the aging station required more upgrades, according to a NASA Office of Inspector General audit.

When the ISS deorbits, NASA doesn't plan to pocket that $3 billion. It plans to spend it buying seats and lab time on private stations. The agency has said this explicitly: it wants to be a "tenant, not a landlord."

Here's what that means in practice. NASA is the anchor tenant for every private station. Not one of the five competitors has publicly disclosed a non-NASA customer commitment large enough to sustain operations. Axiom has run four private astronaut missions to the ISS — Ax-1 through Ax-4 — at roughly $55 million per seat. Those flights generated revenue. They also required the ISS to exist as the destination. When Axiom's own station detaches from the ISS around 2028, the private astronaut missions need to justify themselves without the ISS brand attached.

The Customer List That Doesn't Exist

The bull case for commercial space stations rests on four non-NASA customer categories. Each one has problems.

Space tourism. Axiom charged $55 million per seat for its ISS missions. At that price, the addressable market is maybe 10–20 individuals per year globally. Virgin Galactic sells suborbital tickets for $450,000 and has struggled to fill flights consistently. Orbital tourism at $55 million is not a market. It's a hobby for billionaires.

In-space manufacturing. Varda Space Industries completed the first orbital pharmaceutical manufacturing mission in February 2024, producing ritonavir crystals with superior purity. Real milestone. But Varda uses its own small capsules — it doesn't need a space station. The economics only work for products worth $10,000+ per kilogram. ZBLAN fiber optic manufacturing in microgravity has been "five years away" since 2015.

National space agencies. ESA, JAXA, CSA, and others currently have ISS access through bilateral agreements. Some may buy seats on commercial stations. But their budgets are small — ESA's entire human spaceflight budget is roughly €600 million annually — and they'll negotiate hard. They're price-sensitive customers, not anchor tenants.

Corporate R&D. Merck, Eli Lilly, and Procter & Gamble have run experiments on the ISS through the ISS National Laboratory. Nearly all were small-scale research projects, not production runs. None has committed to ongoing commercial station access. The ISS National Lab facilitated about 600 experiments from 2011 to 2024 — impressive as science, negligible as revenue.

The Math

Operating a space station is staggeringly expensive. Crew rotation, resupply, life support maintenance, ground control staffing. Even with launch costs down 95% from the Shuttle era, the minimum viable operating budget for a crewed commercial station is estimated at $500 million to $1 billion annually.

NASA's CLD budget — $1 to $1.5 billion over five years — covers development support, not operations. When these stations go live, they need paying customers every week, not every quarter.

Do the math. At $55 million per seat and four seats per mission, you need nine or ten fully booked missions per year just to hit $2 billion in revenue — roughly what you'd need to cover operations, debt service on development costs, and margin. That's 36–40 paying customers per year at $55 million each.

There aren't 40 people on Earth willing to spend $55 million for a 10-day orbital stay. Not annually. Not even close.

The Real Model

Vast's CEO, Max Haot, has been more honest than most. Haven-1 is a demonstrator. The company's real play is Haven-2, a larger modular station — and Haot has said publicly that its development depends on NASA CLD Phase 2 funding. Without that contract, Haven-2 doesn't get built.

Axiom's approach is smarter architecturally — attach to the ISS first, piggyback on existing life support and crew rotation, then detach when the modules can stand alone. It's an incremental path that reduces risk. But it's still fundamentally a cost-plus government services business dressed up as a commercial venture.

Orbital Reef has Jeff Bezos's money behind it, which buys patience. Sierra Space and Boeing bring engineering depth. But Blue Origin still hasn't demonstrated rapid launch cadence with New Glenn, and the project's timeline keeps slipping.

Starlab needs Starship to launch in one piece — literally, a single-launch station that requires SpaceX's still-in-development superheavy rocket. Elegant concept. Risky dependency.

What Actually Happens

Most likely: NASA picks one or two winners for Phase 2. Those companies build stations with heavy government subsidy. NASA becomes the 70–80% revenue customer. The stations function as ISS successors, not commercial platforms. Some private astronaut missions happen at the margins. The "commercial space station market" remains, functionally, a government procurement program with better PR.

The optimistic case requires something nobody has demonstrated: a killer app for orbital real estate that generates hundreds of millions in non-government revenue annually. In-space manufacturing could be that, eventually. But the timelines are long and the unit economics are punishing.

Less likely but possible: Starship delivers on its cost promises ($10/kg, eventually), launch prices collapse another 90%, and orbital access becomes cheap enough that entirely new categories of customers emerge. At that point, space stations become infrastructure — the way data centers became infrastructure for the internet. Nobody predicted AWS in 1996.

But betting a $2 billion space station on Starship achieving its aspirational cost targets is not a business plan. It's a prayer.

Sources & References

1. NASA OIG, "NASA's Management of the International Space Station and Efforts to Commercialize Low Earth Orbit," Report IG-21-005 (Nov 2020) — ISS costs ~$3B/year, maintenance costs up 35% 2016–2020
2. NASA Commercial LEO Destinations Program — $415M Phase 1 disbursed, $1–1.5B Phase 2 planned 2026–2031
3. GovCon Wire, "Vast Raises $500M to Advance Haven Space Station Development" (2025)
4. Space.com, Drew Feustel interview on Haven-1 timeline and payload mass (Dec 2025)
5. Axiom Mission 1 — SpaceX Crew Dragon, $55M/seat, launched April 8, 2022 (Wikipedia, sourced from Axiom Space and SpaceX announcements)
6. Singularity Hub, "The Era of Private Space Stations Launches in 2026" — overview of all five competitors and NASA CLD program (Dec 2025)
7. Rocket Lab / Varda Space Industries — first orbital pharmaceutical manufacturing, ritonavir crystals returned Feb 2024 (Rocket Lab press release)
8. ISS National Laboratory — ~600 experiments facilitated 2011–2024 across multiple commercial and academic sponsors
9. Blue Origin, "Orbital Reef" — Haven Demo deployed Nov 2, 2025, mission success confirmed (Blue Origin news)
10. ESA budget overview — total budget ~€7.8B, human spaceflight allocation ~€600M